icsHape (in vivo click selective 2-hydroxyl acylation and profiling experiment) captures rna secondary structure at a transcriptomewide level by measuring nucleotide flexibility at base resolution. living cells are treated with the icsHape chemical naI-n 3 followed by selective chemical enrichment of naI-n 3 -modified rna, which provides an improved signal-to-noise ratio compared with similar methods leveraging deep sequencing. purified rna is then reverse-transcribed to produce cDna, with sHape-modified bases leading to truncated cDna. after deep sequencing of cDna, computational analysis yields flexibility scores for every base across the starting rna population. the entire experimental procedure can be completed in ~5 d, and the sequencing and bioinformatics data analysis take an additional 4-5 d with no extensive computational skills required. comparing in vivo and in vitro icsHape measurements can reveal in vivo rna-binding protein imprints or facilitate the dissection of rna post-transcriptional modifications. icsHape reactivities can additionally be used to constrain and improve rna secondary structure prediction models. These studies demonstrated the utility of chemical probes for understanding the structural elements in mRNAs and noncoding RNAs on a large scale. Rouskin et al. 17 demonstrated that mRNA structures seem to sample many different conformations; however, highly important RNA structures, such as those involved in localization, have similar profiles within and outside the cell. In addition, they demonstrated that ATP-dependent RNA remodeling enzymes (probably helicases) were responsible for the structure probing variation. Ding et al. 18 demonstrated with in vivo DMS profiling that mRNAs associated with stress responses tend to have more single-strandedness, longer maximal loop length and higher free energy per nucleotide. Such features may allow these RNAs to undergo conformational changes in response to environmental conditions. These key studies highlight important examples of information that in vivo RNA structural measurements garner about basic RNA biology. One important limitation of DMS is that it only interrogates two out of four bases in RNA, adenosine (A) and cytosine (C); hence, the structural information is incomplete. To address this limitation, we developed and previously described in vivo click-selective 2′-hydroxyl acylation and profiling experiment or icSHAPE 20 ; here we provide a detailed protocol for icSHAPE. Distinguishing features of our method include the ability to interrogate every position in an RNA, independently of its primary sequence content, and to enrich for modified RNAs to markedly increase the signal-to-noise ratio in transcriptome-wide measurements.
IntroDuctIon
Properly regulated gene expression is critical to the function of normal cells, and alterations in the mechanisms that control gene expression have been linked to several diseases 1 . Although most efforts to understand gene regulation have focused on the role of DNA modification and structure, diverse biological processes are also controlled at the post-transcriptional level.
Mechanisms involving RNA can be found at the heart of many important cellular functions. mRNA is central in the conversion of genetic information in chromatin into protein expression. The ribosome uses RNA functional groups to control peptidyltransferase activity 2 . tRNA maturation is controlled by the RNA enzyme RNaseP 3 . Small RNAs, including miRNAs and piwiinteracting RNAs, have been demonstrated to control the steadystate level of mRNA expression and chromatin remodeling 4 . Elucidating the biochemical basis of such functions is crucial for a complete understanding for how these processes work.
Arguably, all functions of RNA are controlled by RNA's ability to fold into complex secondary and tertiary structures. The majority of RNA structure probing experiments are performed on just a single RNA at a time. These investigations have revealed the intricate details of RNA folding, RNA-protein contacts and metabolite-RNA interactions 5 . In addition, structural studies have also shown that RNA structure has a role in regulating singlegene functions; however, it was only recently indicated that these mechanisms might extend to large groups of RNAs with the observation that RNA structure elements can control the translation of functionally related genes 6 . RNA secondary structure motifs are critical to the regulation of protein binding, subcellular localization and RNA decay. As such, extending our understanding of the structural content of RNA, transcriptome wide, will reveal unique facets of how diverse classes of RNA control the biology of the cell. Recent efforts have been focused on marrying conventional RNA structure probing techniques with genome-scale technologies.
Conventional RNA structure probing techniques RNA structure is frequently measured by chemical modification or RNase digestion. Whereas RNase S1 recognizes and cuts single-stranded regions in RNA, RNase V1 will cleave at doublestranded residues 7 . Small-molecule chemical reagents can instead be used to increase the resolution of structure probing experiments. For example, dimethylsulfate (DMS) can alkylate the Watson-Crick face of adenosine and cytosine, as well as the N7 position of guanosine when not base-paired 8 . Kethoxal is used to modify the N1-and C2-exocyclic amines to reveal singlestranded residues in RNA 9 . Hydroxyl radical probing is widely used to measure RNA compaction and folding; the mechanism used cleaves RNA by hydrogen abstraction at the 5′ position 10 . The recent development of Selective Hydroxyl Acylation analyzed by Primer Extension, or SHAPE, has greatly extended chemical probing experiments because of its ability to interrogate every position in the RNA through 2′-OH reactivity 11 . Overall, the field is well equipped to interrogate the structure of single RNAs.
The next step in the evolution of RNA structure probing is to transition from single-gene analysis to whole-transcriptome interrogation. A corollary can be made to our understanding of gene expression mechanisms and chromatin structure, which has greatly matured since the advent of deep sequencing 12 . Knowledge of the structural content of RNA across the transcriptome will reveal unique facets of how diverse classes of RNA control the biology of the cell.
In vitro transcriptome-wide structure analysis
The first demonstration of the power of transcriptome-wide analysis of RNA structure was the development of Parallel Analysis of RNA Structure (PARS). PARS uses both single (nuclease S1)-and double-stranded (nuclease V1) nucleases to digest motifs in RNA and to generate a structure score 13 . The PARS scores from both experiments can be used to constrain the RNA structure predictions of thousands of transcripts in parallel. In a similar manner, Frag-seq uses nuclease P1 for the cleavage and identification of single-stranded residues 14 . A complementary method, using RNase One and RNase V1, has been used to describe the secondary structures of multiple metazoans 15 . The first chemical-based method to transform structural information Transcriptome-wide interrogation of RNA secondary structure in living cells with icSHAPE into sequencing-based results for understanding the structures of thousands of RNAs in parallel was SHAPE-seq. In SHAPE-seq 16 , a pool of in vitro-transcribed RNAs are subjected to SHAPE chemical probing and deep sequencing. This approach has revealed structural changes that occur because of primary sequence alterations 16 . Although these methods have been very useful for determining the structure of refolded, in vitro transcripts, they are not suitable for describing the structures of RNA inside living cells.
In vivo transcriptome-wide structure analysis DMS was the first chemical that was successfully applied to transcriptome-wide structure probing in living cells, in similar approaches called DMS-seq 17 , Structure-seq 18 and Mod-seq 19 . These studies demonstrated the utility of chemical probes for understanding the structural elements in mRNAs and noncoding RNAs on a large scale. Rouskin et al. 17 demonstrated that mRNA structures seem to sample many different conformations; however, highly important RNA structures, such as those involved in localization, have similar profiles within and outside the cell. In addition, they demonstrated that ATP-dependent RNA remodeling enzymes (probably helicases) were responsible for the structure probing variation. Ding et al. 18 demonstrated with in vivo DMS profiling that mRNAs associated with stress responses tend to have more single-strandedness, longer maximal loop length and higher free energy per nucleotide. Such features may allow these RNAs to undergo conformational changes in response to environmental conditions. These key studies highlight important examples of information that in vivo RNA structural measurements garner about basic RNA biology. One important limitation of DMS is that it only interrogates two out of four bases in RNA, adenosine (A) and cytosine (C); hence, the structural information is incomplete. To address this limitation, we developed and previously described in vivo click-selective 2′-hydroxyl acylation and profiling experiment or icSHAPE 20 ; here we provide a detailed protocol for icSHAPE. Distinguishing features of our method include the ability to interrogate every position in an RNA, independently of its primary sequence content, and to enrich for modified RNAs to markedly increase the signal-to-noise ratio in transcriptome-wide measurements.
Development and overview of icSHAPE icSHAPE was developed to provide both the experimental and computational tools necessary to study RNA structure in a transcriptome-wide manner. Existing high-throughput, chemical-based structure determination methods suffer from high background because of sequencing unmodified RNA [16] [17] [18] . To address this issue, we took inspiration from methods such as RNA-binding protein immunoprecipitation (RIP) 21 and individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP) 22 , in which the signal for RNA binding can be highly enriched by selective purification. We transformed an existing in vivo SHAPE probe 2-methylnicotinic acid imidazolide (NAI) 23 into a dual-function SHAPE probe (RNA structure probe and enrichment), by the addition of an azide to the nicotinic acid ring (at position 2), and we named this molecule NAI-N 3 . Incorporation of the azido-moiety was crucial, as it allowed the 'click' of biotin to the SHAPE reagent using copperfree 'click' chemistry, which proceeds under conditions that are not detrimental to the SHAPE-modified RNA (Fig. 1a) . By the addition of a biotin moiety to each RNA that was successfully SHAPE modified, we are able to subsequently enrich specifically for RNA fragments that have NAI-N 3 covalently attached. We construct icSHAPE cDNA libraries on enriched material, thereby only sequencing structurally informative regions of RNA, thus increasing our signal to noise.
An overview of the icSHAPE procedure is provided in Figure 1b . In brief, the bifunctional NAI-N 3 SHAPE reagent is used to label all RNAs inside living cells (or in vitro refolded RNA) to generate covalent modifications on targeted RNAs at single-nucleotide resolution. RNA is isolated, biotinylated using click chemistry and randomly fragmented to a size of 50-100 nt. To generate cDNA sequencing libraries, the RNA fragments are subjected to 3′-end repair, adapter ligation, size selection, biotin enrichment, reverse transcription (RT) Steps 3-11
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Step 72A/B a b and PCR. The end result is selective amplification of fragments corresponding to modified bases in the NAI-N 3 -treated samples or background expression values from mock-treated samples. Sequencing reads generated from the NAI-N 3 -and mock (DMSO)-treated samples are mapped to a transcriptome annotation, followed by computational identification of RT stops corresponding to SHAPE modifications-and hence reactive nucleotides-across the entire transcriptome (Fig. 1b) . Traditionally, SHAPE reactivity directly reports on the structural flexibility of an individual nucleotide; however, in vivo icSHAPE reactivities can be influenced by protein binding 20 , among other things. We developed a highly modular and customizable computational pipeline to process raw icSHAPE sequencing data and to provide structural output files directly ready for interpretation. The pipeline was designed to take instructions from a centralized configuration file, and users can modify the parameters for each of the processing steps. To accomodate the numerous different strategies that laboratories use to analyze deep-sequencing data, each step taken by the icSHAPE pipeline can be achieved using alternative programs with similar functionality to those described here. The icSHAPE pipeline is capable of running in either 'automatic' or 'manual' modes, thus giving the user speed (automatic) or flexibility (manual) when implementing the analysis package. It should be noted that icSHAPE differs from regular RNA-seq experiments in that (i) icSHAPE profiles a transcript at base resolution, whereas RNA-seq experiments usually quantify transcriptomes and abundances of whole transcripts; (ii) the icSHAPE protocol generates relatively short cDNA inserts of ~20-50 nt; and (iii) in order to obtain base-resolution RNA structure profiles, the sequencing of icSHAPE should be very deep so as to generate sufficient coverage of individual bases. These features require analysis tools that can handle multiply mapping sequencing reads and that can efficiently process billions of reads with potentially limited computational resources and time.
Applications, advantages and limitations of icSHAPE
The use of NAI-N 3 provides an experimental framework for measuring the base flexibility of all four nucleotides in a transcriptome-wide experiment. This principally comes by leveraging SHAPE chemistry, whereas previous in vivo chemical methods have been restricted to interrogating only two of the four bases (As and Cs). Although integrating structural data from multiple probing strategies is ideal, icSHAPE provides a single experimental strategy to capture a global landscape of RNA structure, which is not biased for nucleotide content. An additional advantage of icSHAPE is the specific enrichment of NAI-N 3 -modified RNAs; however, it is formally possible that reverse transcriptase does not always fully extend to the nucleotides modified with NAI-N 3 , thereby possibly generating a false-positive signal. A recent study reported a method for mitigating these effects by digesting non-fully-extended RNA:cDNA hybrids with RNase One 24 . Although this feature is not a part of this protocol, future designs could easily implement this concept.
The principle that 'read counting' allows the user to accurately and quantitatively assess the structural state of a given nucleobase is common to all sequencing-based structure determination methods. Variable amounts of starting material and differential complexity between samples are examples of parameters that contribute to variation across experiments. Generating icSHAPE (or DMS-seq) samples for sequencing requires PCR, and the above-mentioned experimental variables could contribute to differential amplification and/or overamplification of library samples. To combat this, we have incorporated a molecular barcode into the RT primer, which allows for accurate computational removal of PCR duplicates. The molecular barcode therefore allows reads with exactly the same sequence, but generated from unique RNA molecules, to be accurately counted as unique. Our barcode design allows for the precise resolution of >110,000 molecules with the exact same sequence.
Beyond comparing the reactivity profiles of specific transcripts, it is possible to use icSHAPE reactivity values to guide RNA secondary structure prediction. Software, such as RNAstructure 25 , can incorporate icSHAPE and other chemical probing data to constrain the predicted secondary structures, thus improving the accuracy of the prediction. Future work applying novel 26 and integrated computational methods (reviewed in refs. 27-29) will allow for a global view of RNA secondary structure as it exists in vivo and in vitro.
Finally, icSHAPE can be applied to a wide variety of biological systems and questions. Implementation of icSHAPE in vitro and in vivo recapitulated known global structural features of mammalian transcriptomes; however, we also uncovered the ability to read out RNA-protein interactions 20 . We demonstrated the ability to accurately predict protein-binding sites with a high true positive rate. This was accomplished for the proteins RBFOX and HuR, which are proteins that are important for regulating RNA splicing and stability, respectively 20 . In addition, we found that using only icSHAPE reactivities accurately predicted 85% of known m 6 A chemical modifications across the mouse embryonic stem cell (ESC) transcriptome 20 . An independent study further corroborated our finding, using focused biochemistry and traditional RNA structure footprinting 30 . Concurrently, another group developed a biotin-conjugated SHAPE probe that enriches for RNA structural signal, although whether this probe works in living cells was not reported 24 . Overall, these studies demonstrate the power and importance of chemical enrichment strategies, such as icSHAPE, for studying RNA structure in vivo.
Experimental design Controls and replicates.
As with all techniques, replication is crucial to ensuring accurate results. We find that performing icSHAPE with at least two biological replicates (tissue culture cells grown and NAI-N 3 modified on different days) is sufficient. Additional replication can help if the sequencing depth is low and the computational tools provided to analyze icSHAPE data can support an arbitrary number of both mock (DMSO) and modified (NAI-N 3 ) replicates. The design of each icSHAPE experiment should include DMSO samples. The DMSO sample provides an 'input' sample, which allows the computational pipeline to determine whether a given region of RNA was present in the sample. This is critical, as low signal in the NAI-N 3 sample could be due to poor coverage (not enough of that RNA in the sample) or low icSHAPE reactivity (an RNA region with low reactivity toward NAI-N 3 ). In addition to carefully selecting the system and modification parameters, we have found that performing icSHAPE on living cells and deproteinized RNA provides a valuable comparison. Base reactivity of deproteinized, in vitro-folded and NAI-N 3 -modified RNA can provide a transcriptome-wide view of intrinsic RNA structures that form. Base reactivity of in vivo NAI-N 3 -modified RNA will integrate RNA structure and proteinbinding events, among other things. The PROCEDURE describes how to obtain both in vivo-and in vitro-modified RNA. The careful comparison of these independent experiments can yield insights into RNA-binding protein and post-transcriptional RNA modification functions 20 .
RNA amount and source. Transcriptome-wide icSHAPE maps require sufficiently complex pools of input RNA. We have found that 500 ng of input RNA (e.g., poly(A) + or ribosome-depleted) allowed the measurement of base flexibility for >13,000 transcripts 20 . Although the library construction method for icSHAPE is capable of producing high-quality libraries from at least 100× less starting material, we recommend using at least 500 ng when attempting to measure global RNA secondary structure. The PROCEDURE details poly(A) + enrichment coupled to the icSHAPE strategy; however, in principal, any starting RNA material can be used to generate icSHAPE libraries. Specific experimental designs may require purifications to capture non-poly(A) + RNAs (e.g., ribosome depletion strategies) or to focus on RNA classes that are specific to particular sizes (e.g., small-RNA fractionation).
icSHAPE was developed to be broadly applicable and easily implemented. We have tested the NAI-N 3 reagent in bacterial (Gram-negative Escherichia coli), yeast, insect and mammalian cells for SHAPE experiments 23 . All of these systems proved to be amenable for icSHAPE modification and RNA structure determination. We have successfully generated icSHAPE data from experiments in which the in vivo modification occurs at temperatures between 30 and 37 °C, to accommodate the specific culture temperatures. Thus, the procedure can be easily adapted to a wide variety of culture systems to allow transcriptome-wide RNA structure determination in most model systems.
RNA fragmentation. icSHAPE initially is performed on full-length transcripts, probably generating multiple NAI-N 3 modifications per RNA molecule. To identify these SHAPE modification sites via RT-PCR and sequencing, the RNA must be fragmented to smaller sizes. Most strategies have been optimized to achieve single-hit kinetics of chemical modification on short (~100 nt) RNAs, which results in only ~10% of the molecules being structurally informative 11 . Therefore, the procedure describes parameters for metal-based RNA fragmentation to generate small RNAs of ~100 nt. Because icSHAPE reads out truncated cDNA molecules, icSHAPE libraries will be, on average, shorter than the starting RNA length. The final insert size should be taken into consideration during the design of each experiment, as longer or shorter fragments may be advantageous in specific conditions. Sequencing depth. The mass amount of starting material and expected complexity (number of unique transcripts) is important when estimating the depth at which a sample will be sufficiently sequenced. Starting with very little initial RNA mass will probably reduce the complexity of the RNA pool and require the user to perform additional PCR cycles, thereby causing more nonunique reads to exist in the final library sample. In contrast, if the icSHAPE experiment is designed to examine the structure of one RNA or a small number of RNAs, fewer sequencing reads are required to achieve sufficient coverage of the RNA for highquality structure determination. Importantly, the ability to recover only the icSHAPE-modified RNA fragments from the NAI-N 3 sample results in less RNA mass in these samples. Therefore, the DMSO and NAI-N 3 samples will amplify at different times (NAI-N 3 at ~3 PCR cycles after the DMSO), and thus we often dedicate more sequencing depth to the NAI-N 3 samples so as to ultimately achieve the same unique read count as that of the DMSO sample.
MaterIals

REAGENTS
Cells. icSHAPE has been implemented on bacterial, yeast, insect and mammalian cells 23 
Box 1 | icSHAPE software installation and configuration • tIMInG ~4 h
The icSHAPE pipeline requires short read mapping software (e.g., Bowtie2) and transcriptome annotation files (for e.g., .gtf files from the Ensembl project).  crItIcal step In some cases, the annotation file is not complete, or experiment-specific RNA sequences are not included in the Ensembl build. After this step and before the next step, the 'transcriptome.fa' file can be edited to include any RNA sequence of interest as long as the file is kept in FASTA format. 5. Build 5h3 Bowtie2 transcriptome index by using the following command. Here transcriptome.fa is the input FASTA file of all transcripts, and transcriptome is the name of the index library.
$ bowtie2-build transcriptome.fa transcriptome icsHape pipeline installation
The icSHAPE pipeline is a Perl (5.10.1) program designed to be run in the UNIX/Linux environment, including Mac OS, and it has been tested on Red Hat Enterprise Linux Server release 6.3. Below, the prefixing '$' character is the default command prompt. The user only needs to input the command after '$' character for testing or running. 6. Download icSHAPE pipeline. This can be done using github to clone the icSHAPE pipeline from https://github.com/qczhang/icSHAPE and put it into any directory (referred to as installation_directory in step 7 below) by using the following command.
$ git clone https://github.com/qczhang/icSHAPE
For more details on installing software or working with git and github, please see manuals or tutorials on the github website (https://github.com/qczhang/icSHAPE/blob/master/README.md). Alternatively, download a zipped directory of the icSHAPE pipeline from https://github.com/qczhang/icSHAPE/archive/master.zip, and put the package into any installation directory. Unzip it to install. 7. Define environment variables either by adding the following lines to your bash profiles export ICSHAPE=installation_directory export BOWTIELIB=bowtie_index_directory export PATH=$PATH:$ICSHAPE/scripts or by editing the configure file (in installation_directory) so that the pipeline can find scripts and programs used in the pipeline without defining the above environment variables. 8. Open and edit the 'configure' file for additional configurations that specify how the pipeline can find the correct programs (e.g., java, bowtie and icSHAPE binaries and scripts) and scripts (e.g., de-multiplexing, PCR duplicates removal, RT-stop calculation, structural profile calculation, normalization and filtering). Parameters that control the behavior of these programs also can be found in the 'configure' file. 2| Collect adherent cells as described in Option A. Collect suspension cells as described in Option B.  crItIcal step It is important not to trypsinize the plates that will subsequently be used for icSHAPE experiments, as we have found that this results in partially degraded total RNA. icsHape modification and quality control • tIMInG ~2 h 3| Aspirate PBS from the pelleted cells (from Step 2), resuspend the cell pellet in 500 µl of 100 mM NAI-N 3 solution or 500 µl of DMSO solution with a cut-tip p1000 and incubate at 37 °C with rotation for 5 min.  crItIcal step All NAI-N 3 experiments must be paired with a DMSO experiment. DMSO will not modify the RNA, and thus it provides a background signal for determining the coverage level of any given nucleotide in the sequencing experiment.  crItIcal step If you are intending to compare in vivo and in vitro icSHAPE reactivity profiles, which we have shown can reveal biological events such as protein imprints 20 , an additional DMSO sample should be included for subsequent in vitro modification at Step 17 (Box 2).  crItIcal step At least two independent biological replicates should be performed for each condition.
4|
Stop the reaction by centrifuging the samples (2,500g for 1 min at 4 °C) and removing the supernatant.
5|
Resuspend the cells in 500 µl of 1× PBS, and then transfer the cell solution to 6 ml of Trizol LS in a 15-ml tube.
6|
Vortex the samples for ~15 s to homogenize, add 1.2 ml of chloroform (0.2× volumes), vortex again for ~15 s, and then let the samples incubate at 25 °C for 5 min.
7|
Centrifuge the samples (2,500g for 15 min at 4 °C), move the aqueous phase to a new 15-ml tube, add 2× volumes of 96-100% ethanol, and vortex to mix.
8|
Purify RNA using an RNeasy midi kit column according to the manufacturer's protocol (starting at step 4 of the 'RNA Cleanup' section).
9|
Elute RNA from the RNeasy midi column twice with 250 µl of water (final of 500 µl volume).
10| Quantify RNA yield, make 2-µg aliquots for quality control, and then freeze the RNA in 250-µg aliquots at −80 °C for storage.
Box 2 | In vitro icSHAPE modification • tIMInG ~ 1 h
1. Obtain 500 ng of poly(A) + RNA from DMSO-treated cells from Step 17 of the main PROCEDURE and freeze-dry them on a lyophilizer. 2. Resuspend the RNA sample in 5.2 µl of water and move the samples to a PCR tube. 3. Heat-denature the RNA samples at 95 °C for 2 min, and then transfer them to ice to cool. 4. Add 3.3 µl of 3.3× SHAPE reaction buffer, 0.5 µl of RiboLock, and then incubate the samples at 37 °C for 5 min. 5. Add 1 µl of 1 M NAI-N 3 to each sample, flick the tubes gently to mix, and incubate them at 37 °C for 10 min. 6. Stop the reactions by moving the samples to ice and by adding 35 µl of buffer RLT; mix the samples by inversion and then add 100 µl of 100% ethanol. 7. Purify RNA using an RNeasy mini column. Elute the RNA twice with 50 µl of water (100-µl final volume).
Proceed from
Step 18 of the main PROCEDURE.
? trouBlesHootInG 11| Assess RNA quality by agarose gel (1%, wt/vol) analysis. Clear 18S and 28S rRNA bands should be present. ? trouBlesHootInG  pause poInt Purified RNA can be stored at −80 °C for >6 months.
Isolation of poly(a) + rna fraction • tIMInG ~5 h to overnight 12|
For each biological replicate, thaw one 250-µg aliquot of DMSO-treated RNA and in vivo NAI-N 3 -modified RNA (from Step 11) on ice. If you are intending to include in vitro NAI-N 3 -modified RNA in the analysis, thaw an additional DMSO-treated sample, which will be NAI-N 3 -modified at Step 17 after polyA + selection. For a standard experiment aimed at fully characterizing the RNA structure landscape, at least two biological replicates are needed, giving a total of six samples (2× DMSO, 2× in vivo NAI-N 3 and 2× in vitro NAI-N 3 ); however, additional biological replicates can be added for higher confidence.
13|
Isolate poly(A) + RNA using the Poly(A)Purist MAG kit or an equivalent enrichment procedure. Bring each sample to a final elution volume of 400 µl. When using the Poly(A)Purist MAG kit, this will be 400 µl of RNA storage solution (part of the kit).
14| Wash the poly-dT beads once with 500 µl of wash solution 1 and reuse the beads to perform a second poly(A) + enrichment, without purifying the first-step enriched poly(A) + RNA out of the RNA storage solution.  crItIcal step We perform two rounds of poly(A) + RNA enrichment. This ensures the lowest amount of rRNA contamination while still yielding high amounts of poly(A) + RNA for subsequent biochemical reactions.
15|
After the second poly(A) + enrichment, freeze each RNA sample (~400 µl each) for >10 min on dry ice and dry it on a lyophilizer (overnight for convenience).
16|
Resuspend the enriched poly(A) + RNA in 100 µl of water, add 350 µl of buffer RLT, 900 µl of 100% ethanol, and then clean up using an RNeasy mini column. Elute the RNA twice with 50 µl of water (100-µl final volume).
17|
Quantify poly(A) + RNA and make 500-ng aliquots into individual 1.5-ml tubes. For each icSHAPE library reaction, 400-500 ng of RNA is needed for successful library generation.  crItIcal step At this point, two DMSO-treated samples from Step 17 can be used for in vitro NAI-N 3 modification, as described in Box 2.  pause poInt Poly(A) + RNA can be stored at −80 °C for >6 months.
Biotin click reaction of naI-n 3 • tIMInG ~3 h 18| Thaw purified DMSO-and NAI-N 3 -modified poly(A) + RNA (from Step 17 and Box 2) on ice, and then add 2 µl of 1.85 mM DIBO-biotin and 1 µl of RiboLock.
19|
Incubate the samples at 37 °C in a Thermomixer for 2 h at 1,000 r.p.m. Under these conditions, the reaction will proceed to completion with all of the SHAPE adducts finally obtaining a biotin handle 20 .
20| Stop the click reaction by purifying the RNA with a Zymo RNA Clean & Concentrator-5 column according to the manufacturer's protocol. Elute RNA twice in 10 µl of water, and freeze-dry it on a lyophilizer.  pause poInt Biotinylated RNA and DMSO samples can be stored at −80 °C for >6 months.
rna fragmentation and rna end repair • tIMInG ~1.5 h 21| Resuspend the RNA samples from Step 20 in 9 µl of water, preheat a PCR block to 95 °C and move RNA to a PCR tube.
22|
Heat the RNA samples to 95 °C for 60 s, add 1 µl of 10× fragmentation reagent and incubate for 30-60 s.  crItIcal step RNA fragmentation time should be determined empirically by urea PAGE gel analysis. Once it is optimized, fragmenting conditions are highly reproducible. To facilitate accurate timing, only two samples should be processed in parallel for RNA fragmentation.  crItIcal step DMSO-treated RNA samples require a 3′-biotin RNA linker, whereas NAI-N 3 -treated RNA samples require a 3′-ddC RNA linker. This ensures that every RNA molecule from the DMSO sample is recovered, whereas only those RNAs that were icSHAPE-modified are recovered from the NAI-N 3 sample.
27|
Add 30 µl of water to each sample (total volume of 50 µl) and purify RNA with a Zymo RNA Clean & Concentrator-5 column; freeze-dry the sample as in Step 20.
28|
Resuspend RNA in 7 µl of gel loading buffer II, and flick the tube to mix the samples.
29|
Prerun 6% (wt/vol) UreaGel denaturing PAGE, first at 25 W for 3 min and then at 50 W for 5 min. Use a metal (e.g., steel or aluminum) heating plate to evenly disperse the heat across the gel.
30|
Load RNA samples onto the gel, and run them at 50 W for 4-10 min.  crItIcal step These pre-run and run conditions apply to home-poured mini-gels (~8 × 10 cm); longer times will be required to sufficiently heat up larger gels. The duration of the gel run should be sufficient to separate the 3′ RNA linker (~20 nt) from ligated RNA products (more than ~40 nt). However, excessive running times will require large gel slices to be cut at Step 32 and could lower the efficiency of RNA elution.
31|
Stain the gel in SYBR Gold mix for 3 min at 25 °C and image for 0.3 s on a UV transilluminator for record keeping.
32|
Move the gel to a blue light transilluminator, cut the samples above ~45 nt (Fig. 2a) and move the gel slices into 0.65-ml tubes nested in 2-ml tubes. Each 0.65-ml tube should be prepared with a needle (18-22 G) hole at the bottom of the tube.
33|
Centrifuge the samples (16,000g for 5 min at 25 °C) and discard the 0.65-ml tube.
34|
Add 250 µl of water to each sample and heat it to 70 °C for 10 min, with shaking at 1,000 r.p.m. in a Thermomixer.
35|
Pulse-centrifuge each sample, transfer the gel slurry into a Spin-X column with a cut-tip p1000 and centrifuge (6,500g for 1 min at 25 °C) the sample.
36|
Resuspend the gel in the top chamber of the Spin-X column with 250 µl of water, and repeat Steps 34 and 35 to obtain a final 500-µl elution volume. Reuse the Spin-X columns for the second elution.
37|
Transfer the 500-µl eluate to a 0.5-ml 10K Amicon column and centrifuge the sample (13,500g for 5 min at 25 °C). This should concentrate the sample to ~100 µl.
38|
Elute the samples as per the manufacturer's instructions: flip the Amicon column over into a new 2-ml elution tube and centrifuge the samples (2,000g for 2 min at 25 °C). 43| Add 10 µl of streptavidin bead solution, mix by pipetting up and down until the sample is homogeneous, and then incubate the sample at 25 °C for 45 min with rotation.
39|
44|
Apply the samples to DynaMag-96 side magnet for 1 min, and remove 25 µl of supernatant.
45|
Add 100 µl of 4 M SHAPE wash buffer to each sample and transfer the samples to 1.5-ml siliconized tubes. Add an additional 400 µl (500 µl final) of 4 M SHAPE wash buffer and invert the tubes four times to mix.
46|
Apply the samples to a DynaMag2 magnet for 1 min, and then remove the supernatant.
47|
Add 500 µl of 4 M SHAPE wash buffer to each sample and repeat Steps 46 and 47 four more times (a total of 5 washes).
48|
Add 500 µl of 1× PBS to each sample and repeat once more (a total of two washes).
49|
Resuspend the beads in 50 µl of RNaseA/T1/H elution mix (tabulated below) and incubate them at 37 °C for 30 min at 1,000 r.p.m. in a Thermomixer. 
52|
Resuspend cDNA in 7 µl of Gel loading buffer II, and flick to mix the samples.
53|
Prerun 6% (wt/vol) denaturing PAGE, first at 25 W for 3 min, and then at 50 W for 5 min. During the pre-run, boil samples for 2 min at 95 °C, and then place them on ice for 1 min.
54|
Load cDNA samples onto the gel and run them at 50 W for 4-10 min.
55| Stain, image and cut the gel as above for the RNA size selection (Steps 31 and 32). See Figure 2b for representative results.  crItIcal step It is important to separate the cDNA products from any excess unextended RT primer, which will run at ~50 nt. Isolation of cDNA >70 nt (~20 nt of cDNA and ~50 nt of RT primer) will provide sufficient insert sequence length for high-confidence mapping to mammalian genomes.
56|
Crush the gel slices, elute cDNA, filter over a Spin-X and concentrate with 10K Amicon columns, as in Steps 37 and 38. 
63|
Load the samples onto a 6% (wt/vol) native PAGE gel and run them at 160 V for ~25 min.
64| Stain the gel in SYBR Gold mix for 3 min at 25 °C and image for 0.3 s on a UV transilluminator for record keeping.
65|
Move the gel to a blue light transilluminator and cut the samples above ~150 bp. See Figure 2c for representative results.  crItIcal step Library PCR may generate other products, such as primer-dimer species. These will run at ~120-130 bp and should be avoided; contamination of library material with primer-dimer will lower the clustering density of the final icSHAPE library on deep-sequencing platforms. 68| Quantify 1 µl of each library using a high-sensitivity Bioanalyzer chip, pool the desired samples for multiplexing if necessary, and sequence icSHAPE libraries on an Illumina-based machine using standard conditions. icSHAPE libraries are paired-end compatible; however, 75-bp single-end sequencing is sufficient to identify RT stops and to confidently map to mammalian transcriptomes. As the random and experimental barcodes are 'in-line', the standard Illumina 6-or 8-nt barcode read should be omitted.
icsHape data analysis • tIMInG ~1-2 d 69| Obtain the raw sequencing reads from
Step 68 and unzip if necessary. Sequencing reads usually will be in the FASTQ file format. Sometimes they are zipped to save space (as in our example .fastq file, provided at https://github.com/qczhang/ icSHAPE/blob/master/data/test/hiseq.nanog.fastq). If this is the case, they need to be unzipped by using the 'unzip' command (or 'gunzip' if the file is 'gzipped', which is usually implied by the suffix ' .gz'): 71| Check the quality of the reads from the FASTQ files using a sequencing quality control program such as FastQC. This tool can be used to produce summary graphs and tables that inform the user of potential problems in the data. For example, the software can readily identify low-quality sequence, and it usually suggests that the user trim the read to exclude this region. Use the following command to run FastQC:
$ fastqc -o out_directory libX.fastq 72| Run the icSHAPE pipeline either automatically, as described in Step 72A, or manually, as described in Step 72B. The configure file is a tab-delimited text file, and it contains information for the input data, and on where to look for specific programs and their associated parameters. For example, the key 'FASTQCODING' defines the coding of input FASTQ reads, and the key 'COLLAPSEBIN' specifies which program to use to remove PCR duplicates. Although many important keys will be discussed in the following sections, please see the associated 'readme' file (https://github. com/qczhang/icSHAPE/blob/master/README.md) for a complete description of the icSHAPE pipeline.
The pipeline will create a directory called 'test' and put all intermediate files and final output into the directory. Please see Figure 1b for the workflow of the pipeline and table 1 for the intermediate files generated in each step.
Here we first convert the reactivity score for each base in the transcript coordinates into genome coordinates (file icSHAPE.out from the Step 72B(ix)) and then merge genome positions that are covered by multiple transcripts. Finally, convert the .bedgraph file to a .bw file by using the UCSC utility 'bedGraphToBigWig' . The file 'genome.chr.size' contains the lengths of all chromosomes of the investigated genome.
? trouBlesHootInG Troubleshooting advice can be found in table 2.
• tIMInG Steps 1 and 2, cell culture: ~10 min 
antIcIpateD results
The icSHAPE protocol generates many experimental data points, all of which are diagnostic of prior steps. RNA fragmentation and ligation can be assessed by urea PAGE (Step 31); an even smear of RNA signal is expected. The RNA linker will be easily identified as a band just larger than 25 nt, with the preadenylylated and 3′-biotin blocked RNA linker (DMSO samples) running more slowly than the preadenylylated and 3′-ddc blocked RNA linker (Fig. 2a) . At
Step 55, the cDNA Urea PAGE can visualize the RT and enrichment of NAI-N 3 -modified fragments (Fig. 2b) . The cDNAs generated from the DMSO sample should closely match the distribution of the RNA fragments that were initially size-selected at Step 31; however, they will be characteristically longer owing to incorporation of the long RT primer that is capable of later intramolecular circularization. The cDNAs generated from the NAI-N 3 -modified sample will be both shorter and less abundant because of the NAI-N 3 causing structure-dependent stops along the RNA molecule and the 'single-hit' kinetics the cells were modified under, respectively. The final library native PAGE at Step 64 will confirm the qPCR amplification of specific icSHAPE products. It is important to remove any PCR primer-dimer products (Fig. 2c) , as these will efficiently cluster on the deep-sequencing platforms and absorb valuable sequencing reads. After deep sequencing, each icSHAPE read provides information about the reactive base (i.e., where the reverse transcriptase stops). Sequencing reads from each library are collapsed to remove PCR duplicates. In our protocol, we use a complex barcoding system that contains a fixed region to represent different libraries and two random regions (9 nt in total) to distinguish PCR duplicates from fragments with identical sequences. This is important to retain the quantitative nature of the experiment across a large number of PCR cycles between DMSO and NAI-N 3 experiments. As a consequence, usually there are many identical fragments that correspond to the same modification (i.e., reactive) site. These identical but meaningful fragments cannot be distinguished from duplicates that arise from subsequent PCR amplification steps without additional information. The random part of the barcodes is designed to solve this problem, because the chance for two random fragments to receive the same barcode is low (1/4 9 ). The icSHAPE pipeline thus identifies duplicated PCR reads as those that are fully identical, including both the insert and the barcode regions.
Within the unique set of reads, RT stops generated from NAI-N 3 -induced truncations are identified as the first base in the sequencing read after the 13-nt barcode region. As reverse transcriptase characteristically stops one base downstream of the modified nucleotide, we computationally shift the RT stop to the (-) 1 position to correctly identify the flexible base. This position is the fragmentation position in the DMSO libraries. For each base, the RT stop count is then summed across the whole sequencing library, yielding an RT-stop coverage value. RT-stop coverage values of all bases across each transcript are then normalized with a 5-5% procedure, in which the means of the RT stops of top 90-95% of bases are normalized to 1, and all RT stops are scaled proportionally. It should be noted that because the experimental protocol usually introduces some degree of bias (difficulties in efficiently sequencing the 5′ ends of RNAs and a 'blind 3′-end tail' because of low mapping of short reads), the current icSHAPE pipeline excludes the 32 bases at the 5′ and 3′ ends of the transcript in normalization. Reactivity scores for each base in a transcript are then calculated as the difference between background RT stops (DMSO samples) from icSHAPE RT stops (NAI-N 3 samples), and then adjusted by the background base density:
The reactivity score is then scaled to the range of [0, 1], after removing the outliers by 90% Winsorization (the top fifth percentile is set to 1 and the bottom fifth percentile is set to 0). This is performed for each transcript independently. The parameter α is designed to remove the effect of natural fall-over of reverse transcriptase from a transcript in mock-treated libraries when calculating RT stops-e.g., RT stops caused by endogenous modifications in DMSO libraries. As the treated and mock-treated libraries are sequenced differently, this parameter does not equal to 1, and it was trained on mouse rRNA structures and set to 0.25 to maximize the correlation of reactivity score R, determined by deep sequencing and reactivity score measured in low-throughput gel-shift experiments 23 . Finally, the structural profile of each transcript is defined as the vector of reactivity score of every base from the beginning to the end, and the valid structural profile of a transcript is filtered by only selecting those regions that pass certain RT stop coverage threshold and background base density threshold. Figure 3 | icSHAPE reactivities of Nanog (Nanog homeobox) mRNA. A 7-kb region centered on the Nanog locus is shown with two isoforms of the Nanog mRNA in the mm10 build of the mouse genome. In vivo (red) and in vitro icSHAPE experimental data are represented as tracks with values ranging from 0 to 1. The vivo-vitro difference (VTD) score for each base is shown in gray.
